Our healthcare law firm works with many providers and healthcare practices to assist them in complying with federal, state, and local laws. Several of our clients have asked if they can administer ketamine for off-label use, especially for treatment-resistant depression. Ketamine has started being administered in psychiatric practices and ketamine clinics, and states are starting to respond to the proliferation of these ketamine clinics.
On March 31, 2026, our firm wrote a blog post about a bill in the Georgia General Assembly that proposed to regulate ketamine clinics. On May 12, 2026, Georgia Governor Brian Kemp signed this bill, meaning the bill is set to become law on July 1, 2026, unless the bill gives another effective date for certain portions of it. This updated blog post discusses the new law that will regulate ketamine clinics. If you are planning to administer ketamine in your practice, would like to set up a ketamine clinic, or would like to discuss this blog post, you may contact our healthcare law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.
The new law, House Bill 717 (HB 717), will regulate facilities that administer “psychedelic-assisted treatment and therapy,” which includes ketamine that is administered intravenously. “Psychedelic-assisted treatment and therapy” is defined as any treatment or therapy using psychedelic, dissociative, or other related substances that can produce hallucinations or other similar feelings. The new law will also cover other treatments similar Continue reading ›























